Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
alopecia
Biotech
Q32 Bio sticks with bempikibart but lets go of staff
Despite the failure of an eczema trial, Q32 is staying faithful to bempikibart. But a number of the biotech’s “valued colleagues” won’t be so lucky.
James Waldron
Feb 11, 2025 4:47am
Q32's stock plunges in wake of anti-IL-7R antibody's eczema fail
Dec 11, 2024 8:25am
Soterios looks to ph. 3 after win for alopecia areata cream
May 30, 2024 8:14am
Amgen's lupus bets continue to tumble, even those on the Horizon
Jul 24, 2023 8:59am
Do hairy moles hold the key to treating hair loss?
Jun 22, 2023 5:01am
Sun's $576M Concert hits bum note as FDA imposes partial hold
May 2, 2023 7:09am